Skip to main content
Premium Trial:

Request an Annual Quote

Susan Rolih

Meridian Bioscience said this week that Susan Rolih, executive VP of global regulatory and quality systems, will retire on Nov. 30, 2018. She worked for the firm for 18 years and is expected to serve as a consultant on an as-requested basis with matters related to FDA remediation efforts at the firm's Magellan Diagnostics business, among other matters.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.